Not all individuals with CLL demand therapy. Regardless of all the latest advancements, the iwCLL nevertheless suggests watchful observation for individuals with asymptomatic disease.86 This suggestion relies on at the very least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). adalah situs judi https://lauraf186xfn2.webbuzzfeed.com/profile